Home › Funds › TCG Crossover Management, LLC › DNTH

TCG Crossover Management, LLC position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

TCG Crossover Management, LLC reported holding 1,676,624 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$163.4M, representing 3.93% of its reported portfolio and ranking #7 among its reported holdings. TCG Crossover Management, LLC has disclosed DNTH holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.68M sh
Reported value held$163.44M
Portfolio Weight3.93%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's DNTH position evolved

TCG Crossover Management, LLC first disclosed a stake in DNTH in Q4 2024 at 1,501,624 shares (US$32.7M). The position peaked in Q2 2026 at 1,676,624 shares, worth US$163.4M. Across 7 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,676,624 shares valued at US$163.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.50M $32.74M New
Q1 2025 1.50M $27.24M Hold
Q2 2025 1.50M $27.98M Hold
Q3 2025 1.68M $65.98M Add
Q4 2025 1.68M $69.09M Hold
Q1 2026 1.68M $140.70M Hold
Q2 2026 1.68M $163.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has TCG Crossover Management, LLC held DNTH?

TCG Crossover Management, LLC has disclosed DNTH holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is TCG Crossover Management, LLC's current position in DNTH?

As of Q2 2026, TCG Crossover Management, LLC holds 1.68M shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $163.44M, representing 3.93% of its reported portfolio and ranking #7.

Has TCG Crossover Management, LLC been buying or selling DNTH?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in DNTH. The position peaked in Q2 2026 at 1.68M shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.